Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents

Published:2011-05 Issue:5 Volume:4 Page:530-542
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Stone Gregg W.,Ellis Stephen G.,Colombo Antonio,Grube Eberhard,Popma Jeffrey J.,Uchida Takahiro,Bleuit Jill S.,Dawkins Keith D.,Russell Mary E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions;Grube;Circulation,2003

2. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I);Grube;Am J Cardiol,2005

3. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions;Colombo;Circulation,2003

4. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions;Silber;Circulation,2009

5. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents;Journal of Clinical Medicine;2023-10-24

2. Less Is More: Developments in Nanotechnology for Antirestenosis Therapies;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-07

3. Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention;Medicine;2022-11-11

4. The path to a hemocompatible cardiovascular implant: Advances and challenges of current endothelialization strategies;Frontiers in Cardiovascular Medicine;2022-09-14

5. Short Term Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug Eluting Stents: A Comprehensive Review of Literature;Current Problems in Cardiology;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3